Company news
Cynata Therapeutics Limited news in 2026
Cynata Therapeutics Limited's news releases, calls and decks from 2026, newest first.
Change in substantial holding
November 5, 2026
Proposed issue of securities - CYP
November 3, 2026
Commitments received for further $550k via placement
November 3, 2026
Appendix 3Y-Ms Janine Rolfe
November 2, 2026
Appendix 3Y-Dr Kilian Kelly
November 2, 2026
Appendix 3Y-Dr Geoffrey Brooke
November 2, 2026
Notification regarding unquoted securities - CYP
November 2, 2026
Notification regarding unquoted securities - CYP
November 2, 2026
Application for quotation of securities - CYP
November 2, 2026
Cleansing Notice
October 30, 2026
Application for quotation of securities - CYP
October 30, 2026
Consultancy Agreement
October 29, 2026
Results of Fully Underwritten Entitlement Offer
October 29, 2026
Results of Fully Underwritten Entitlement Offer
October 29, 2026
September 2026 Quarterly Activity Report & Appendix 4C
October 26, 2026
Letter to Shareholders, Notice of AGM & Proxy Form
October 22, 2026
Paul Wotton to Resign as Director from AGM
October 21, 2026
Unmarketable Parcel Sale Facility
October 19, 2026
Notification of buy-back - CYP
October 19, 2026
Letter to Ineligible Shareholders-Entitlement Offer
October 15, 2026
Letter to Eligible Shareholders-Entitlement Offer
October 15, 2026
Replacement Target Market Determination
October 12, 2026
Replacement Prospectus
October 12, 2026
Target Market Determination
October 7, 2026
Prospectus
October 7, 2026
Proposed issue of securities - CYP
October 7, 2026
Proposed issue of securities - CYP
October 7, 2026
Entitlement Offer & Unmarketable Parcel Sale Facility
October 7, 2026
Termination of At-the-Market Subscription Deed
October 7, 2026
Cynata Receives R&D TI Refund & Repays R&D TI Loan
October 6, 2026
R&D Tax Incentive Loan Facility Extension
September 29, 2026
Date of AGM and Closing Date for Director Nominations
September 29, 2026
Appendix 4G
September 28, 2026
Corporate Governance Statement
September 28, 2026
Annual Report
September 28, 2026
Notification under Listing Rule 4.3D
September 23, 2026
Notification of cessation of securities - CYP
September 10, 2026
Appendix 4E & Preliminary Final Report
August 30, 2026
Proposed issue of securities - CYP
August 25, 2026
June 2026 Quarterly Activity Report & Appendix 4C
July 29, 2026
Board, Management Changes, Expenditure Reductions, RDTI Loan
July 5, 2026
Reinstatement to Official Quotation
June 18, 2026
CYP-001 GvHD Trial Primary Evaluation Results
June 16, 2026
Suspension from Quotation
June 15, 2026
EU Positive Opinion on CYP-001 Paediatric Investigation Plan
June 2, 2026
Cynata Secures Commitments for $1.5m Placement
May 3, 2026
March 2026 Quarterly Activity Report & Appendix 4C
April 30, 2026
Last Visit in GvHD Trial Completed
March 29, 2026
Appendix 4D & Half-Year Financial Statements
February 26, 2026
December 2025 Quarterly Activity Report and Appendix 4C
January 28, 2026